Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1999 Apr;80(4):380–383. doi: 10.1136/adc.80.4.380

Henoch-Schönlein purpura

E Tizard 1
PMCID: PMC1717896  PMID: 10086951

Full Text

The Full Text of this article is available as a PDF (84.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ateş E., Bakkaloğlu A., Saatçi U., Söylemezoğlu O. von Willebrand factor antigen compared with other factors in vasculitic syndromes. Arch Dis Child. 1994 Jan;70(1):40–43. doi: 10.1136/adc.70.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bunchman T. E., Mauer S. M., Sibley R. K., Vernier R. L. Anaphylactoid purpura: characteristics of 16 patients who progressed to renal failure. Pediatr Nephrol. 1988 Oct;2(4):393–397. doi: 10.1007/BF00853428. [DOI] [PubMed] [Google Scholar]
  3. Chaussain M., de Boissieu D., Kalifa G., Epelbaum S., Niaudet P., Badoual J., Gendrel D. Impairment of lung diffusion capacity in Schönlein-Henoch purpura. J Pediatr. 1992 Jul;121(1):12–16. doi: 10.1016/s0022-3476(05)82533-8. [DOI] [PubMed] [Google Scholar]
  4. Counahan R., Winterborn M. H., White R. H., Heaton J. M., Meadow S. R., Bluett N. H., Swetschin H., Cameron J. S., Chantler C. Prognosis of Henoch-Schönlein nephritis in children. Br Med J. 1977 Jul 2;2(6078):11–14. doi: 10.1136/bmj.2.6078.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. De Mattia D., Penza R., Giordano P., Del Vecchio G. C., Aceto G., Altomare M., Schettini F. von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura. Pediatr Nephrol. 1995 Oct;9(5):603–605. doi: 10.1007/BF00860949. [DOI] [PubMed] [Google Scholar]
  6. Fujieda M., Oishi N., Naruse K., Hashizume M., Nishiya K., Kurashige T., Ito K. Soluble thrombomodulin and antibodies to bovine glomerular endothelial cells in patients with Henoch-Schönlein purpura. Arch Dis Child. 1998 Mar;78(3):240–244. doi: 10.1136/adc.78.3.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gianviti A., Trompeter R. S., Barratt T. M., Lythgoe M. F., Dillon M. J. Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis. Arch Dis Child. 1996 Sep;75(3):186–190. doi: 10.1136/adc.75.3.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goldstein A. R., White R. H., Akuse R., Chantler C. Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet. 1992 Feb 1;339(8788):280–282. doi: 10.1016/0140-6736(92)91341-5. [DOI] [PubMed] [Google Scholar]
  9. Ha T. S., Cha S. H. Cerebral vasculitis in Henoch-Schönlein purpura: a case report with sequential magnetic resonance imaging. Pediatr Nephrol. 1996 Oct;10(5):634–636. doi: 10.1007/s004670050177. [DOI] [PubMed] [Google Scholar]
  10. Hughes F. J., Wolfish N. M., McLaine P. N. Henoch-Schönlein syndrome and IgA nephropathy: a case report suggesting a common pathogenesis. Pediatr Nephrol. 1988 Oct;2(4):389–392. doi: 10.1007/BF00853426. [DOI] [PubMed] [Google Scholar]
  11. Iijima K., Ito-Kariya S., Nakamura H., Yoshikawa N. Multiple combined therapy for severe Henoch-Schönlein nephritis in children. Pediatr Nephrol. 1998 Apr;12(3):244–248. doi: 10.1007/s004670050447. [DOI] [PubMed] [Google Scholar]
  12. Jardim H. M., Leake J., Risdon R. A., Barratt T. M., Dillon M. J. Crescentic glomerulonephritis in children. Pediatr Nephrol. 1992 May;6(3):231–235. doi: 10.1007/BF00878354. [DOI] [PubMed] [Google Scholar]
  13. Kaku Y., Nohara K., Honda S. Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of prognostic factors. Kidney Int. 1998 Jun;53(6):1755–1759. doi: 10.1046/j.1523-1755.1998.00915.x. [DOI] [PubMed] [Google Scholar]
  14. Koskimies O., Mir S., Rapola J., Vilska J. Henoch-Schönlein nephritis: long-term prognosis of unselected patients. Arch Dis Child. 1981 Jun;56(6):482–484. doi: 10.1136/adc.56.6.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lin J. J., Stewart C. L., Kaskel F. J., Fine R. N. IgG and IgA classes of anti-neutrophil cytoplasmic autoantibodies in a 13-year-old girl with recurrent Henoch-Schonlein purpura. Pediatr Nephrol. 1993 Apr;7(2):143–146. doi: 10.1007/BF00864379. [DOI] [PubMed] [Google Scholar]
  16. Meadow S. R., Glasgow E. F., White R. H., Moncrieff M. W., Cameron J. S., Ogg C. S. Schönlein-Henoch nephritis. Q J Med. 1972 Jul;41(163):241–258. [PubMed] [Google Scholar]
  17. Meadow S. R., Scott D. G. Berger disease: Henoch-Schönlein syndrome without the rash. J Pediatr. 1985 Jan;106(1):27–32. doi: 10.1016/s0022-3476(85)80459-5. [DOI] [PubMed] [Google Scholar]
  18. Meadow S. R. The prognosis of Henoch Schoenlein nephritis. Clin Nephrol. 1978 Mar;9(3):87–90. [PubMed] [Google Scholar]
  19. Meulders Q., Pirson Y., Cosyns J. P., Squifflet J. P., van Ypersele de Strihou C. Course of Henoch-Schönlein nephritis after renal transplantation. Report on ten patients and review of the literature. Transplantation. 1994 Dec 15;58(11):1179–1186. [PubMed] [Google Scholar]
  20. Mills J. A., Michel B. A., Bloch D. A., Calabrese L. H., Hunder G. G., Arend W. P., Edworthy S. M., Fauci A. S., Leavitt R. Y., Lie J. T. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum. 1990 Aug;33(8):1114–1121. doi: 10.1002/art.1780330809. [DOI] [PubMed] [Google Scholar]
  21. Mollica F., Li Volti S., Garozzo R., Russo G. Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr. 1992 Feb;151(2):140–144. doi: 10.1007/BF01958961. [DOI] [PubMed] [Google Scholar]
  22. Niaudet P., Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis. Pediatr Nephrol. 1998 Apr;12(3):238–243. doi: 10.1007/s004670050446. [DOI] [PubMed] [Google Scholar]
  23. Nielsen H. E. Epidemiology of Schönlein-Henoch purpura. Acta Paediatr Scand. 1988 Jan;77(1):125–131. doi: 10.1111/j.1651-2227.1988.tb10610.x. [DOI] [PubMed] [Google Scholar]
  24. Oner A., Tinaztepe K., Erdogan O. The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis. Pediatr Nephrol. 1995 Feb;9(1):6–10. doi: 10.1007/BF00858954. [DOI] [PubMed] [Google Scholar]
  25. Ostergaard J. R., Storm K. Neurologic manifestations of Schönlein-Henoch purpura. Acta Paediatr Scand. 1991 Mar;80(3):339–342. doi: 10.1111/j.1651-2227.1991.tb11859.x. [DOI] [PubMed] [Google Scholar]
  26. Robson W. L., Leung A. K. Henoch-Schönlein purpura. Adv Pediatr. 1994;41:163–194. [PubMed] [Google Scholar]
  27. Ronda N., Esnault V. L., Layward L., Sepe V., Allen A., Feehally J., Lockwood C. M. Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch-Schönlein purpura. Clin Exp Immunol. 1994 Jan;95(1):49–55. doi: 10.1111/j.1365-2249.1994.tb06013.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Saulsbury F. T. Antinuclear antibody in Henoch-Schönlein purpura. Am J Med Sci. 1986 Mar;291(3):180–182. doi: 10.1097/00000441-198603000-00007. [DOI] [PubMed] [Google Scholar]
  29. Saulsbury F. T. Corticosteroid therapy does not prevent nephritis in Henoch-Schönlein purpura. Pediatr Nephrol. 1993 Feb;7(1):69–71. doi: 10.1007/BF00861574. [DOI] [PubMed] [Google Scholar]
  30. Saulsbury F. T. The role of IgA1 rheumatoid factor in the formation of IgA-containing immune complexes in Henoch-Schönlein purpura. J Clin Lab Immunol. 1987 Jul;23(3):123–127. [PubMed] [Google Scholar]
  31. Smith G. C., Davidson J. E., Hughes D. A., Holme E., Beattie T. J. Complement activation in Henoch-Schönlein purpura. Pediatr Nephrol. 1997 Aug;11(4):477–480. doi: 10.1007/s004670050320. [DOI] [PubMed] [Google Scholar]
  32. Stewart M., Savage J. M., Bell B., McCord B. Long term renal prognosis of Henoch-Schönlein purpura in an unselected childhood population. Eur J Pediatr. 1988 Feb;147(2):113–115. doi: 10.1007/BF00442205. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES